Dr. Judith Richter - Founder and Chief Executive Officer
Dr. Judith Richter is an accomplished entrepreneur and among the most distinguished business leaders within the Israeli industry. Dr. Richter, who co-founded Medinol in 1993, has been its Chief Executive Officer ever since.
Under her leadership, Medinol fundamentally transformed the interventional cardiology industry through innovation and revolutionary technology. With an extremely cost efficient manufacturing operation and best-in-class products, Dr. Richter grew Medinol to become a significant player in the stenting industry internationally, highly reputable for its commitment to promote scientific advances and health.
Concurrent with Medinol, Dr. Richter is the founder and an active board member of several other private medical device companies – all focusing on the development of novel devices and breakthrough innovations in the medical field. In addition, Dr. Richter serves as a board member of Mobileye NV, listed on NYSE.
Previously, Dr. Richter founded and served as the CEO of Medcon Ltd., a global provider of web-based cardiac imaging and information management. Dr. Richter successfully led the business until it was acquired by McKesson in 2005.
Among other business engagements, Dr. Richter served on the board of several Israeli corporations, including Bezeq Ltd. Dr. Richter also held a senior position at Teva Pharmaceutical Industries Ltd., one of the largest pharmaceutical companies in the world.
Dr. Richter’s extensive experience in the industry was preceded by a career in the academia. Dr. Richter was a faculty member for over 10 years at Tel-Aviv University’s Graduate School of Business, where she specialized in corporate strategy and decision making under uncertainty.
Today, Dr. Richter serves as a member of the Executive Committee of The Hebrew University of Jerusalem.
Dr. Richter is the recipient of the Ramniceanu Prize in Economics for 2013 awarded by Tel-Aviv University in recognition for her exceptional contribution to Israel's economic, industrial and technological development. She is also an Honorary Fellow of The Hebrew University of Jerusalem since 2013.
Dr. Kobi Richter - Founder, Chairman and Chief Technology Officer
Dr. Yoram Richter - Chief Scientific Officer
Dr. Eran Kaplan - VP R&D and Technologies
Michal Hershkovitz - VP Clinical & Regulatory Affairs
Dr. Daniel Levy - VP Quality
Dr. Oleg Weizman - VP Innovative Technologies
Sachi Gerlitz - President Sales and Marketing
Efi Haber Naor – VP HR and Infrastructure
Harvey J. Berger, M.D. – Executive Chairman Medinol USA
Harvey J. Berger, M.D. joined Medinol as Executive Chairman of Medinol USA in January 2017. At Medinol Dr. Berger is focused on worldwide business development and global strategy, new business and technology initiatives and expanding operational efficiencies worldwide. He is working with Medinol’s core business of interventional cardiovascular devices, as well as its new businesses of developing sub-millimeter implantable sensors, unique percutaneous aortic valves and other complimentary medical products.
Dr. Berger brings over 35 years of experience in the medical and biotechnology fields. Prior to joining Medinol, he was the Chairman and Chief Executive Officer of ARIAD Pharmaceuticals, Inc. since founding the company over 25 years earlier, in which time the company developed into one of the leading global commercial oncology companies. It was acquired by Takeda Pharmaceuticals, Ltd. In 2017 and incorporated into Takeda Oncology.
Dr. Berger was a Professor at Yale, Emory and University of Pennsylvania medical schools. He received his M.D. from Yale School of Medicine and did further medical and post-graduate training at Massachusetts General Hospital and Yale-New Haven Hospital. He was the award winner of the Ernst & Young Entrepreneur of the Year Award in New England and the Gold Stevie Award as Executive of the Year
Matt W. Donnelly – General Manager Medinol USA
Dafna Perlovitch - VP Finance
Dov Amar – VP Global Manufacturing Operations
Dov Amar joined Medinol in 2016 and leads the global manufacturing operations of the company.
Prior to joining Medinol, Mr. Amar held different positions in the metal and pharmaceutical industries. In his most recent position, Mr. Amar worked at Teva Pharmaceutical Industries. In his last position he assumed the role of Vice President TAPI (Teva API) global supply chain. Previously Mr. Amar held different positions in Teva's European Operations and Global Supply Chain organizations. Prior to working for Teva, Mr. Amar was the Vice President Operations at Carmel Forge, a subsidiary of Pratt & Whitney.
Mr. Amar holds a B.Sc. in Industrial Engineering and Management from the Technion - Israel Institute of Technology and an MBA in Finance and Accounting from the Tel Aviv University.